⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001903781

Louria Hayon Igal

Reports to the SEC for 1 company · TEL AVIV-JAFFA

Transactions

5

Companies

1

Filings

3

CIK

0001903781

Forms 4 and 5

Insider transactions

5 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-20	RAPHRaphael Pharmaceutical Inc.X Exercise of In-Money	Chief Technology Officer	XExercise of In-Money	+350K sh	$0.01	+$3,500	1,349,000
2025-11-20	RAPHRaphael Pharmaceutical Inc. · Warrants to purchase Common StockX Exercise of In-Money	Chief Technology Officer	XExercise of In-Money	−350K sh	—	—	0
2023-08-29	RAPHRaphael Pharmaceutical Inc.X Exercise of In-Money	Chief Technology Officer	XExercise of In-Money	+999K sh	$0.01	+$9,990	999,000
2023-08-29	RAPHRaphael Pharmaceutical Inc. · Warrants to purchase Common StockX Exercise of In-Money	Chief Technology Officer	XExercise of In-Money	−999K sh	—	—	0
2022-12-05	RAPHRaphael Pharmaceutical Inc. · Warrants to Purchase Common StockA Award	Chief Technology Officer	AAward	+999K sh	—	—	990,000

Recent filings

3

Accepted (ET)
Apr 64
Louria Hayon Igal0001213900-26-040590
SEC(opens sec.gov)
Mar 254
Louria Hayon Igal0001213900-24-025519
SEC(opens sec.gov)
Mar 134
Louria Hayon Igal0001213900-23-019554
SEC(opens sec.gov)

Companies

1

Raphael Pharmaceutical Inc.Chief Technology OfficerRAPH

Address

TEL AVIV-JAFFA, 6803605